Cosmetics News and Research

RSS

FDA issues new emergency use authorization for BinaxNOW COVID-19 Ag Card Home Test

Today, the U.S. Food and Drug Administration issued a new emergency use authorization (EUA) for the BinaxNOW COVID-19 Ag Card Home Test which is authorized for use by patients at home with a prescription.

16 Dec 2020

FDA grants marketing authorization for new ACL implant

Today, the U.S. Food and Drug Administration granted marketing authorization—under the De Novo premarket review pathway—for an anterior cruciate ligament (ACL) implant, intended to serve as an alternative to ACL reconstruction to treat ACL tears.

16 Dec 2020

FDA issues emergency use authorization for first fully at-home OTC COVID-19 diagnostic test

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first over-the-counter (OTC) fully at-home diagnostic test for COVID-19.

15 Dec 2020

Hazardous chemicals in plastics threaten human health

Plastics contain and leach hazardous chemicals, including endocrine-disrupting chemicals (EDCs) that threaten human health.

15 Dec 2020

Study: Silica offers the best environmental alternative to plastic microbeads

Following bans on plastic microbeads in wash-off cosmetics, a new study weighs up the environmental costs of alternatives. Microbeads have been included in personal care and cosmetic products ranging from toothpaste and sunscreen to body scrubs and industrial hand cleaners, usually to improve qualities like abrasiveness.

15 Dec 2020

FDA approves first IGA in GalSafe pigs for human food, promising therapeutic uses

Today, the U.S. Food and Drug Administration approved a first-of-its-kind intentional genomic alteration (IGA) in a line of domestic pigs, referred to as GalSafe pigs, which may be used for food or human therapeutics.

15 Dec 2020

FDA approves first COVID-19 direct-to-consumer test

Today, the U.S. Food and Drug Administration authorized LabCorp's Pixel COVID-19 Test Home Collection Kit for use by any individual 18 years and older without a prescription.

9 Dec 2020

FDA authorizes first COVID-19 test to detect COVID-19, influenza A and B

Today, the U.S. Food and Drug Administration authorized the first diagnostic test for at home collection of patient samples to detect both COVID-19 and influenza A and B (flu).

7 Dec 2020

Plasma treatment decreases movement of plasticizers from blood bags

Medical products such as blood bags and tubing are often made from soft PVC, a plastic that contains phthalate plasticizers, which are suspected to be harmful to human health.

4 Dec 2020

First PSMA-targeted PET imaging drug approved for men with prostate cancer

Today, the U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) - the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer.

1 Dec 2020

FDA issues guidance on use of dry heat to support reuse of certain respirators

Today, the U.S. Food and Drug Administration issued guidance on the use of dry heat to help support the single-user reuse of certain particulate filtering facepiece respirators (FFRs), such as N95 respirators, by health care personnel when there is a limited supply of respirators during the COVID-19 public health emergency.

25 Nov 2020

FDA expands approved indication for influenza treatment to include post-exposure prevention

Today, the U.S. Food and Drug Administration expanded the approved indication for Xofluza (baloxavir marboxil) to include post-exposure prevention of influenza (flu) for patients 12 years of age and older after contact with an individual who has the flu.

23 Nov 2020

California law banning toxic chemicals in cosmetics will transform industry

A toxic chemical ban signed into law in California will change the composition of cosmetics, shampoos, hair straighteners and other personal care products used by consumers across the country, industry officials and activists say.

23 Nov 2020

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.

23 Nov 2020

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.

23 Nov 2020

FDA approves first COVID-19 diagnostic test for at-home use

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test for self-testing at home and that provides rapid results.

18 Nov 2020

Study: Cannabidiol molecule contains more potent antioxidants

Nowadays, cannabidiol is a star component, not only in the world of cosmetics, but also in pharmaceutics and nutrition due to its antioxidant properties and its therapeutical potential.

17 Nov 2020

First intratumoral injection approved by FDA for treating non-metastatic mast cell tumors in dogs

Today, the U.S. Food and Drug Administration approved Stelfonta (tigilanol tiglate injection) to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs).

17 Nov 2020

FDA authorizes marketing of new device intended to provide temporary relief from sleep disturbances

Today, the U.S. Food and Drug Administration permitted marketing of a new device intended for the temporary reduction of sleep disturbance related to nightmares in adults 22 years or older who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder (PTSD).

8 Nov 2020

FDA releases final guidance to help identify and prevent insanitary conditions at compounders’ facilities

Protecting patients from exposure to poor quality compounded drugs is a fundamental part of the U.S. Food and Drug Administration's drug compounding program, and we are committed to protecting patients.

6 Nov 2020

Cosmetics News and Research

FDA issues new emergency use authorization for BinaxNOW COVID-19 Ag Card Home Test

FDA grants marketing authorization for new ACL implant

FDA issues emergency use authorization for first fully at-home OTC COVID-19 diagnostic test

Hazardous chemicals in plastics threaten human health

Study: Silica offers the best environmental alternative to plastic microbeads

FDA approves first IGA in GalSafe pigs for human food, promising therapeutic uses

FDA approves first COVID-19 direct-to-consumer test

FDA authorizes first COVID-19 test to detect COVID-19, influenza A and B

Plasma treatment decreases movement of plasticizers from blood bags

First PSMA-targeted PET imaging drug approved for men with prostate cancer

FDA issues guidance on use of dry heat to support reuse of certain respirators

FDA expands approved indication for influenza treatment to include post-exposure prevention

California law banning toxic chemicals in cosmetics will transform industry

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

FDA approves first COVID-19 diagnostic test for at-home use

Study: Cannabidiol molecule contains more potent antioxidants

First intratumoral injection approved by FDA for treating non-metastatic mast cell tumors in dogs

FDA authorizes marketing of new device intended to provide temporary relief from sleep disturbances

FDA releases final guidance to help identify and prevent insanitary conditions at compounders’ facilities

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News